Exploring Nanocarriers as Treatment Modalities for Skin Cancer
Molecules · 05.08.2023 · 28 (15) · 5905
DOI: 10.3390/molecules28155905 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 05.08.2023. Verfasst von Mohammad Adnan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Integral University, Lucknow 226026, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Skin Neoplasms, Nanoparticles, Drug Carriers, Antineoplastic Agents. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Khalid University, Deanship of Scientific Research at King Khalid University.
Abstract (Originalsprache)
Cancer is a progressive disease of multi-factorial origin that has risen worldwide, probably due to changes in lifestyle, food intake, and environmental changes as some of the reasons. Skin cancer can be classified into melanomas from melanocytes and nonmelanoma skin cancer (NMSC) from the epidermally-derived cell. Together it constitutes about 95% of skin cancer. Basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC) are creditworthy of 99% of NMSC due to the limited accessibility of conventional formulations in skin cancer cells of having multiple obstacles in treatment reply to this therapeutic regime. Despite this, it often encounters erratic bioavailability and absorption to the target. Nanoparticles developed through nanotechnology platforms could be the better topical skin cancer therapy option. To improve the topical delivery, the nano-sized delivery system is appropriate as it fuses with the cutaneous layer and fluidized membrane; thus, the deeper penetration of therapeutics could be possible to reach the target spot. This review briefly outlooks the various nanoparticle preparations, i.e., liposomes, niosomes, ethosomes, transferosomes, transethosomes, nanoemulsions, and nanoparticles technologies tested into skin cancer and impede their progress tend to concentrate in the skin layers. Nanocarriers have proved that they can considerably boost medication bioavailability, lowering the frequency of dosage and reducing the toxicity associated with high doses of the medication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Integral University, Lucknow 226026, Uttar Pradesh, India.
- School of Pharmaceutical and Population Health Informatics (SoPPHI), DIT University, Dehradun 248009, Uttarakhand, India.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha 62521, Saudi Arabia.
- Smart-Health Initiative (SHI) and Red Sea Research Center (RSRC), Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi…
- Core Labs, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.
ORCID-Profile: Md Habban Akhter, Obaid Afzal, Irfan Ahmad, Manal A Alossaimi, Abdul-Hamid Emwas, Tanweer Haider, Md Faheem Haider
Förderung
- King Khalid University
- Deanship of Scientific Research at King Khalid University
Zitieren
APA
Adnan, M., Akhter, M. H., Afzal, O., Altamimi, A. S. A., Ahmad, I., Alossaimi, M. A., Jaremko, M., Emwas, A. H., Haider, T., & Haider, M. F. (2023). Exploring Nanocarriers as Treatment Modalities for Skin Cancer. Molecules, 28(15), 5905. https://doi.org/10.3390/molecules28155905
Vancouver
Adnan M, Akhter MH, Afzal O, Altamimi ASA, Ahmad I, Alossaimi MA, et al. Exploring Nanocarriers as Treatment Modalities for Skin Cancer. Molecules. 2023;28(15):5905. doi:10.3390/molecules28155905
BibTeX
@article{Adnan2023,
author = {Adnan, Mohammad and Akhter, Md Habban and Afzal, Obaid and Altamimi, Abdulmalik S A and Ahmad, Irfan and Alossaimi, Manal A and Jaremko, Mariusz and Emwas, Abdul-Hamid and Haider, Tanweer and Haider, Md Faheem},
title = {Exploring Nanocarriers as Treatment Modalities for Skin Cancer},
journal = {Molecules},
year = {2023},
volume = {28},
number = {15},
pages = {5905},
doi = {10.3390/molecules28155905}
}
EUVIMED